Oct 7, 2026 08:33AM
Oct 7, 2026 08:30AM
Oct 1, 2026 08:33AM
Oct 1, 2026 08:31AM
Oct 1, 2026 08:30AM
Oct 1, 2026 08:30AM
Sep 2, 2026 08:30AM RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
Aug 25, 2026 08:31AM
Aug 25, 2026 08:30AM
Aug 21, 2026 08:30AM
Aug 21, 2026 08:30AM
Aug 20, 2026 08:30AM
Aug 20, 2026 08:30AM
Aug 12, 2026 04:05PM RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
Aug 11, 2026 08:32AM
Aug 11, 2026 08:30AM
Aug 6, 2026 08:31AM
Aug 6, 2026 08:30AM
Aug 4, 2026 08:30AM
Jul 29, 2026 08:30AM
Jun 11, 2026 08:30AM RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic Cancer
Jun 4, 2026 08:30AM
May 28, 2026 08:31AM
May 28, 2026 08:30AM
May 26, 2026 08:32AM
May 26, 2026 08:30AM
May 19, 2026 08:30AM
May 14, 2026 04:05PM RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter
Apr 29, 2026 08:30AM
Apr 23, 2026 08:30AM
Apr 14, 2026 08:30AM
Apr 8, 2026 08:30AM
Apr 8, 2026 08:30AM
Apr 1, 2026 02:20PM
Mar 30, 2026 04:05PM RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
Mar 26, 2026 08:30AM
Mar 26, 2026 08:30AM
Mar 24, 2026 09:51AM
Mar 23, 2026 08:31AM
Mar 23, 2026 08:30AM
Mar 23, 2026 08:30AM
Mar 20, 2026 08:30AM RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET
Mar 18, 2026 08:35AM
Mar 18, 2026 08:35AM
Feb 27, 2026 08:30AM
Feb 26, 2026 08:30AM
Feb 10, 2026 08:30AM
Feb 10, 2026 08:30AM
Feb 5, 2026 08:30AM RenovoRx names Mark Voll as chief financial officer
Feb 5, 2026 08:30AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All